Mismatch negativity as an early biomarker of cognitive impairment in schizophrenia

Mismatch negativity as an early biomarker of cognitive impairment in schizophrenia

Abstract Background Due to its disturbance in schizophrenic patients, mismatch negativity (MMN) generation is believed to be a potential biomarker for recognizing primary impairments in auditory sensory processing during the course of the disease. However, great controversy exists regarding the type...

Full description

Bibliographic Details
Main Authors: Abeer Mamdouh Ali Mahmoud, Mai Abd-Elraoof Eissa, Enaas Ahmad Kolkaila, Reham Abdel Rahman Amer, Mona Ahmed Kotait
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Early schizophrenia
Chronic schizophrenia
Mismatch negativity
Biomarker
Cognitive impairment
Psychometric tests
Online Access:https://doi.org/10.1186/s41983-023-00627-5

Similar Items

Similar Items